These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16440039)

  • 1. [Use of estrogen replacement therapy and alternative therapies among Norwegian women aged 50-69].
    Dahle EJ; Lydersen S; Moen MH
    Tidsskr Nor Laegeforen; 2006 Jan; 126(3):318-20. PubMed ID: 16440039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 1997 May; 76(5):442-8. PubMed ID: 9197447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and previous use of oral contraceptives among Swedish women.
    Hammar M; Brynhildsen J; Dabrosin L; Frisk J; Lindgren R; Nedstrand E; Wyon Y
    Maturitas; 1996 Nov; 25(3):193-9. PubMed ID: 8981336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatives to hormone replacement therapy: a multi-method study of women's experiences.
    Wathen CN
    Complement Ther Med; 2006 Sep; 14(3):185-92. PubMed ID: 16911898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
    Bakken K; Eggen AE; Lund E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy among Norwegian women. Self-reported use and sales of estrogen preparations].
    Søgaard AJ; Fønnebø V; Magnus JH; Tollan A
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):590-5. PubMed ID: 9520588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
    Antoine C; Ameye L; Paesmans M; Rozenberg S
    Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogen and natural products in the treatment of postmenopausal complaints. Oral contraceptives prepare the way for hormonal substitution].
    Hammar M; Frisk J; Brynhildsen J; Dabrosin L; Lindgren R; Nedstrand E; Wyon Y
    Lakartidningen; 1997 Mar; 94(12):1084-8. PubMed ID: 9121242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan.
    Nagata C; Matsushita Y; Shimizu H
    Maturitas; 1996 Nov; 25(3):201-7. PubMed ID: 8981337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
    Szántó F
    Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years.
    Buhling KJ; Daniels BV; Studnitz FS; Eulenburg C; Mueck AO
    Complement Ther Med; 2014 Feb; 22(1):94-8. PubMed ID: 24559823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the use of medication for climacteric complaints in western Europe--II.
    Oddens BJ; Boulet MJ; Lehert P; Visser AP
    Maturitas; 1994 May; 19(1):1-12. PubMed ID: 7935027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of hormone replacement therapy use in Italian women, 1992-1996.
    Chiaffarino F; Parazzini F; La Vecchia C; Bianchi MM; Benzi G; Ricci E; Chiantera V
    Maturitas; 1999 Oct; 33(2):107-15. PubMed ID: 10597874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.